Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis

Mendel E Singer; David C Kaelber; Maria J Antonelli

doi:10.1136/annrheumdis-2020-218500

Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis

Ann Rheum Dis. 2022 Aug 11;81(9):e161. doi: 10.1136/annrheumdis-2020-218500.

Authors

Mendel E Singer¹, David C Kaelber^{2

3}, Maria J Antonelli⁴

Affiliations

¹ Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA mendel@case.edu.
² Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
³ Internal Medicine and Pediatrics, The MetroHealth System, Cleveland, Ohio, USA.
⁴ Internal Medicine and Rheumatology, Case Western Reserve University at The MetroHealth System, Cleveland, Ohio, USA.

PMID: 32759263
DOI: 10.1136/annrheumdis-2020-218500

No abstract available

Keywords: arthritis; communicable diseases; health care; hydroxychloroquine; imported; lupus erythematosus; outcome assessment; rheumatoid; systemic.

Publication types

Letter